Here are a few takeaways from Signant’s presentations that you may have missed:

Dr. Miller led a product showcase, Glimmers of Hope: Facilitating Breakthroughs in Dementia Clinical Trials, that demonstrated how Signant, the first company to implement electronic assessments in dementia clinical trials, applies rater training, data quality management, and eCOA to optimize endpoint reliability in these trials.

 

Our clinical vice president, Dr. David Miller, presented the poster “Impact of Protocol Design on Between Scale Discrepancies in Early AD Clinical Trials.”
Download the Poster

Our analytics guru, Dr. Alan Kott, presented the poster “Exploring Discordant Data in Dementia Clinical Trials.”
Download the Poster

To learn more about why Signant is the global leader in dementia clinical research, and reach out to our in-house experts to discuss your dementia programs.

Signant Health

Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently generate quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 20 years, over 400 sponsors and CROs of all sizes – including all of Top 20 pharma – have trusted Signant Health solutions for remote and site-based eCOA, eConsent, IRT, supply chain management, and data quality analytics.

Recent Posts

eConsent

eConsent Task Force Co-Chaired by Signant and Medidata Honored as Finalists for TOPRA Innovation Award

Learn more

eCOA

3 Reasons Oncology Studies Should Consider a Pre-Configured eCOA Solution

Learn more

eCOA

EMA Draft Guidance: Here’s What It Tells Us About BYOD

Learn more

Clinical Supplies

Direct-to-Patient Clinical Supply Distribution: Everything You Need to Know

Learn more

Telemedicine & Virtual Monitoring

The Inaugural IMAGINE FORUM Recap

Learn more